RWS
BBIO icon

Retirement Wealth Solutions’s BridgeBio Pharma BBIO Stock Holding History

Retirement Wealth Solutions’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38K Sell
21
-1
-5% -$78 ﹤0.01% 677
2026
Q2 		$1.64K Sell
22
-2
-8% -$140 ﹤0.01% 557
2026
Q1 		$1.78K Buy
24
+1
+4% +$72 ﹤0.01% 527
2025
Q4 		$1.76K Buy
+23
New +$1.51K ﹤0.01% 481

Other funds holding BBIO

CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Retirement Wealth Solutions's BBIO Position: Q3 2026 in Review

Retirement Wealth Solutions reduced its BridgeBio Pharma (BBIO) stake by 4.5% in Q3 2026, selling an estimated $78 and leaving 21 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Retirement Wealth Solutions first reported a position in BBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.78K in Q1 2026. 12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Retirement Wealth Solutions held 21 shares of BridgeBio Pharma worth $1.38K as of Q3 2026.
  • Retirement Wealth Solutions sold 1 BridgeBio Pharma share in Q3 2026, an estimated $78.
  • BridgeBio Pharma made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q3 2026, its #677 holding.
  • Retirement Wealth Solutions first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 4 quarters since.
  • Retirement Wealth Solutions's BridgeBio Pharma position peaked at $1.78K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Retirement Wealth Solutions's 13F filing for Q3 2026, filed 7 Oct 2026.